文献速递甲状腺疾病

放射性碘相关克隆性造血在甲状腺癌中常见且与生存期缩短相关

Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

该研究在279例晚期甲状腺癌患者中评估克隆性造血(CH)与放射性碘(RAI)暴露的关系。结果显示CH患病率为37%,CH潜在驱动突变(CH-PD)为5.2%;RAI剂量与CH及CH-PD风险独立相关,且既往暴露于RAI的CH-PD患者生存期显著更差。

要点

  • 晚期甲状腺癌患者中CH患病率为37%,CH-PD为5.2%。
  • RAI剂量每增加10 mCi,CH和CH-PD的比值比分别增加2%和4%。
  • 既往暴露于RAI的CH-PD患者生存期显著更差(HR=3.75,95%CI 1.23–11.5,P=0.02)。

核心结论

  • RAI暴露与甲状腺癌患者中高 prevalenc 的CH相关,CH是血液系统恶性肿瘤的前驱状态。

研究设计与样本

  • 在279例晚期甲状腺癌患者中评估CH、CH-PD及总生存期。

主要发现

  • 甲状腺癌患者CH患病率为37%,CH-PD患病率为5.2%。
  • 年龄是CH和CH-PD的最强预测因素,年龄每增加1岁,CH和CH-PD的比值比分别增加5%和13%。
  • 校正年龄、外照射放疗和化疗后,RAI剂量仍与CH和CH-PD显著相关;RAI剂量每增加10 mCi,CH和CH-PD的比值比分别增加2%和4%。
  • 既往暴露于RAI的CH-PD患者生存期显著更差,即使按年龄分层(HR=3.75,95%CI 1.23–11.5,P=0.02)。

临床怎么用

  • 对于考虑接受RAI治疗的甲状腺癌患者,可识别CH以评估风险是否可能超过RAI治疗的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Radioactive iodine (RAI) has been epidemiologically associated with the development of hematologic malignancies. Clonal hematopoiesis (CH) is a precursor clonal state that confers increased risk of leukemia and occurs at an elevated rate in patients with thyroid cancer relative to other solid tumors. OBJECTIVE: We explore if the high prevalence of CH may be a result of RAI exposure and whether CH may be a surrogate in the association between RAI and leukemia. DESIGN: CH, CH-potential driver (CH-PD), and overall survival were evaluated in 279 patients with advanced thyroid carcinoma. RESULTS: The prevalence of CH in patients with thyroid cancer was 37%, and that of CH-PD was 5.2%. Age was the strongest predictor of CH and CH-PD. For every year increase in age, there was a 5% and 13% increase in the odds of CH and CH-PD, respectively. RAI dose was significantly associated with CH and CH-PD, even after adjustment for age, external beam radiation therapy, and chemotherapy. For every 10 mCi increase in the dose of RAI administered, there was a 2% and 4% increase in the odds of CH and CH-PD, respectively. Patients with CH-PD previously exposed to RAI had a significantly poorer survival, even when stratified by age (heart rate = 3.75, 95% CI = 1.23 to 11.5, P = 0.02). CONCLUSIONS: RAI was associated with a high prevalence of CH, and CH is a precursor state of hematologic malignancies. The implications of this study may favor identification of CH in patients where the risks might outweigh the benefits of receiving RAI therapy for thyroid cancer.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Boucai L, Falcone J, Ukena J, et al. Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival. J Clin Endocrinol Metab. 2018. PMID: 30137527. doi:10.1210/jc.2018-00803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。